Weekly News Roundup – Pharma Acquisitions, Trial Triumphs, and Coding Controversies

tHEORetically Speaking
12/09/2025 4 min Temporada 4 Episodio 13
Weekly News Roundup – Pharma Acquisitions, Trial Triumphs, and Coding Controversies

Listen "Weekly News Roundup – Pharma Acquisitions, Trial Triumphs, and Coding Controversies"

Descargar episodio

Episode Synopsis

This week’s tHEORetically Speaking News Roundup covers new research on social-genetic influences in adolescent depression, Novartis’s $1.4B acquisition of Tourmaline Bio for a promising heart drug, and encouraging Phase 2 results for rezatapopt in solid tumors. We also explore the FDA’s draft guidance on non-opioid pain treatments and the AMA’s release of 2026 CPT codes amid growing scrutiny.Tune in for this concise recap of these pivotal industry updates! 

More episodes of the podcast tHEORetically Speaking

Weekly News Roundup — Tariff-Free Pharma, Biologics Modernization, Duchenne Trial Success, and Maternal Health Advances 05/12/2025
Weekly News Roundup — Premium Hikes, Predictive AI Breakthroughs, and Public Health Policy Fallout 21/11/2025
Weekly News Roundup — Four Big Moves in Medtech, Neurotech, Biopharma R&D & Pharma M&A 14/11/2025
Weekly News Roundup – FDA Shakeups, Novo Nordisk’s Strategic Reset, and Smart Data for Diabetes Innovation 07/11/2025
Weekly News Roundup – Neuro Breakthroughs, Biosimilar Reform, and an Obesity Drug Showdown 31/10/2025
Weekly News Roundup – Real-World Wins and Billion-Dollar Breakthroughs 24/10/2025
INsights & OUTcomes with Dalfoni Banerjee 21/10/2025
Weekly News Roundup – CAR-T Safety Alerts, Policy Ripple Effects, and Notable Wearables 17/10/2025
Weekly News Roundup – Immunology, Innovation, and Impact 10/10/2025
tHEORetically Speaking: Rethinking Decentralization in Direct-to-Patient Studies 06/10/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA